Commercial Solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
WHO WE HELP
-
Pharmaceutical Manufacturers
-
MedTech
-
Emerging Biopharma
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialties
-
Patient Organizations
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
MedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover Innovations
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialties
Embrace digital innovation in healthcare and transform your organization with a suite of cutting-edge registry solutions.
EXPLORE SOLUTIONS
Patient Organizations
Maximize your patient impact with expert guidance, data-driven insights, and a suite of cutting-edge patient data solutions.
DRIVE PATIENT IMPACTU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
Webinar
"Collaborative Intelligence: Empowering the Human-AI Workforce in Life Sciences
REGISTER NOWWhite Paper
The Path to CAR T–Cell Therapy
Uncovering barriers to patient access
Oct 20, 2025
Unlock the Promise of CAR T-Cell Therapy
CAR T-cell therapies have revolutionized cancer treatment, offering new hope for patients with relapsed or refractory B-cell lymphomas, leukemias, and multiple myeloma. Since their FDA approval in 2017, these therapies have demonstrated superior efficacy and acceptable risk profiles, leading to expanded indications and streamlined regulatory oversight. Yet despite their transformative potential, access remains a critical challenge. This white paper, The Path to CAR T–Cell Therapy: Uncovering Barriers to Patient Access, explores the systemic hurdles that prevent eligible patients from receiving life-saving treatment and highlights the urgent need for improved referral pathways, education, and coordination across the healthcare ecosystem.
Based on IQVIA's 2024 research, the findings reveal that two-thirds of eligible patients are never referred to a treatment center, and fewer than 20% ultimately receive CAR T-cell therapy. This paper offers actionable insights for healthcare providers, treatment centers, patient advocacy groups, and manufacturers to close the gap between clinical innovation and real-world impact. Learn how standardized referral frameworks, digital tools, and multilingual education campaigns can help overcome logistical and financial barriers.
Download now to be part of the solution and help expand access to one of the most promising cancer therapies of our time.
Related solutions
Brand & Marketing
Grow your brand, now and through patent expiry
Market Access
Gain high value access and increase the profitability of your brands